Page last updated: 2024-08-21

orcinol and Liver Neoplasms

orcinol has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akentiev, AV; Besra, SE; Bikov, AG; Gajbhiye, RL; Guha, P; Jaisankar, P; Karmakar, G; Nag, K; Nahak, P; Noskov, BA; Panda, AK; Roy, B	1

Other Studies

1 other study(ies) available for orcinol and Liver Neoplasms

Article	Year
Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines. Pharmaceutical research, 2018, Aug-27, Volume: 35, Issue:10 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Glucosides; Humans; Lipids; Liver Neoplasms; Mice; Nanostructures; Oleic Acids; Particle Size; Polyethylene Glycols; Resorcinols; Solubility; Stomach Neoplasms; Triglycerides; Ultrasonic Waves	2018

Article

Year

Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.

Pharmaceutical research, 2018, Aug-27, Volume: 35, Issue:10

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Glucosides; Humans; Lipids; Liver Neoplasms; Mice; Nanostructures; Oleic Acids; Particle Size; Polyethylene Glycols; Resorcinols; Solubility; Stomach Neoplasms; Triglycerides; Ultrasonic Waves

2018